Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation


Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation

Ordemann, R.; Stöhlmacher, J.; Beuthien-Baumann, B.; Platzek, I.; van den Hoff, J.; Kroschinsky, F.; Middeke, J. M.; Platzbecker, U.; Zietz, C.; Bornhäuser, M.; Ehninger, G.

Letter to the editor - kein Abstract verfügbar

Permalink: https://www.hzdr.de/publications/Publ-17499
Publ.-Id: 17499